Geode Capital Management
ALIM

Geode Capital Management’s Alimera Sciences ALIM Stock Holding History

Geode Capital Management’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-638,396
Closed -$3.55M – 4605
2024
Q2 		$3.55M Buy
638,396
+260,159
+69% +$924K ﹤0.01% 2908
2024
Q1 		$1.48M Buy
378,237
+46,260
+14% +$176K ﹤0.01% 3229
2023
Q4 		$1.43M Buy
331,977
+279,153
+528% +$943K ﹤0.01% 3211
2023
Q3 		$164K Sell
52,824
-6,500
-11% -$21.5K ﹤0.01% 4058
2023
Q2 		$173K Buy
59,324
+21,062
+55% +$48.3K ﹤0.01% 4103
2023
Q1 		$79.2K Hold
38,262
– – ﹤0.01% 4411
2022
Q4 		$103K Sell
38,262
-58
-0.2% -$247 ﹤0.01% 4395
2022
Q3 		$194K Buy
38,320
+12,002
+46% +$73K ﹤0.01% 4231
2022
Q2 		$143K Buy
26,318
+1,227
+5% +$6.75K ﹤0.01% 4430
2022
Q1 		$140K Hold
25,091
– – ﹤0.01% 4530
2021
Q4 		$128K Hold
25,091
– – ﹤0.01% 4643
2021
Q3 		$106K Hold
25,091
– – ﹤0.01% 4656
2021
Q2 		$228K Buy
25,091
+3,219
+15% +$31.6K ﹤0.01% 4291
2021
Q1 		$210K Buy
21,872
+7,966
+57% +$65.3K ﹤0.01% 4100
2020
Q4 		$58K Hold
13,906
– – ﹤0.01% 4145
2020
Q3 		$67K Hold
13,906
– – ﹤0.01% 3972
2020
Q2 		$87K Buy
13,906
+549
+4% +$2.87K ﹤0.01% 3890
2020
Q1 		$51K Buy
13,357
+3,078
+30% +$18.7K ﹤0.01% 3922
2019
Q4 		$77K Buy
10,279
+496
+5% +$2.96K ﹤0.01% 4017
2019
Q3 		$83K Hold
9,783
– – ﹤0.01% 3985
2019
Q2 		$130K Hold
9,783
– – ﹤0.01% 3893
2019
Q1 		$155K Buy
9,783
+130
+1% +$1.98K ﹤0.01% 3800
2018
Q4 		$103K Hold
9,653
– – ﹤0.01% 3850
2018
Q3 		$141K Hold
9,653
– – ﹤0.01% 3857
2018
Q2 		$141K Hold
9,653
– – ﹤0.01% 3803
2018
Q1 		$149K Hold
9,653
– – ﹤0.01% 3762
2017
Q4 		$192K Sell
9,653
-787
-8% -$15.4K ﹤0.01% 3689
2017
Q3 		$211K Hold
10,440
– – ﹤0.01% 3655
2017
Q2 		$217K Sell
10,440
-362
-3% -$7.76K ﹤0.01% 3653
2017
Q1 		$226K Buy
10,802
+49
+0.5% +$944 ﹤0.01% 3615
2016
Q4 		$174K Buy
10,753
+1,028
+11% +$18.8K ﹤0.01% 3662
2016
Q3 		$217K Buy
9,725
+8
+0.1% +$184 ﹤0.01% 3572
2016
Q2 		$179K Sell
9,717
-1,957
-17% -$52K ﹤0.01% 3627
2016
Q1 		$306 Sell
11,674
-8
-0.1% -$249 ﹤0.01% 3465
2015
Q4 		$424K Buy
11,682
+1,406
+14% +$61K ﹤0.01% 3349
2015
Q3 		$340K Buy
10,276
+16
+0.2% +$901 ﹤0.01% 3416
2015
Q2 		$709K Buy
10,260
+711
+7% +$49K ﹤0.01% 3058
2015
Q1 		$717K Buy
9,549
+1,329
+16% +$105K ﹤0.01% 3039
2014
Q4 		$683K Buy
8,220
+1,423
+21% +$115K ﹤0.01% 3038
2014
Q3 		$552K Buy
6,797
+1,689
+33% +$144K ﹤0.01% 3119
2014
Q2 		$458K Buy
5,108
+308
+6% +$27.3K ﹤0.01% 3207
2014
Q1 		$568K Buy
4,800
+626
+15% +$60.8K ﹤0.01% 3095
2013
Q4 		$294K Buy
4,174
+1,522
+57% +$62K ﹤0.01% 3299
2013
Q3 		$150K Buy
2,652
+388
+17% +$24.4K ﹤0.01% 3404
2013
Q2 		$166K Buy
+2,264
New +$131K ﹤0.01% 3288

Geode Capital Management's ALIM Position: Q3 2024 in Review

Geode Capital Management sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 638,396 shares — an estimated $3.55M sold.

Geode Capital Management first reported a position in ALIM in Q2 2013 and held it in 45 quarters. The position peaked at $3.55M in Q2 2024. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.

  • Geode Capital Management reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
  • Geode Capital Management sold 638,396 Alimera Sciences shares in Q3 2024, an estimated $3.55M.
  • Geode Capital Management first reported a position in Alimera Sciences in Q2 2013 and held it in 45 quarters.
  • Geode Capital Management's Alimera Sciences position peaked at $3.55M in Q2 2024.
  • 0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.

Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.